Stay updated on Amcenestrant in ER+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Amcenestrant in ER+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Amcenestrant in ER+ Breast Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.4.2 added; the notice about government funding lapse and the prior Revision: v3.4.1 entry were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T01:49:15.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Site-wide government funding notice about potential delays and the NIH operating status has been added. The page revision tag was updated from v3.4.0 to v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-04T00:21:23.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added a glossary toggle and new result-status timestamps (Results First Posted, Last Update Submitted that Met QC Criteria, Last Update Posted) and updated the site revision to v3.4.0. Removed the older estimated fields and No FEAR Act data indicators.
    Difference
    0.2%
    Check dated 2026-01-27T23:20:35.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.3.4 replaces v3.3.3 on this page, a minor UI/backend update with no impact on study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-13T18:32:38.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Locations sections were added, detailing multiple study sites across the US (Colorado, Massachusetts, New York, Washington) and international sites (Alberta, British Columbia, Ontario, Milano, Pomeranian Voivodeship, Cardiff, Oxfordshire). Several prior location blocks were removed, and the page revision label updated to v3.3.3.
    Difference
    0.9%
    Check dated 2025-12-23T02:36:38.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Results have been posted on 2025-11-24, and the page now lists expanded study locations including Milano, Cardiff, Vancouver, Brno, Prague, Lille, Lyon, Villejuif, and Madrid. The update also adds detailed endpoints and PK/PD data across multiple arms (DLTs, ORR, CBR, DOR, PFS, etc.).
    Difference
    7%
    Check dated 2025-12-01T16:24:11.000Z thumbnail image

Stay in the know with updates to Amcenestrant in ER+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Amcenestrant in ER+ Breast Cancer Clinical Trial page.